Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000776 | kinetochore | 3 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H6B3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 113 | 117 | PF00656 | 0.416 |
CLV_C14_Caspase3-7 | 16 | 20 | PF00656 | 0.538 |
CLV_C14_Caspase3-7 | 178 | 182 | PF00656 | 0.305 |
CLV_C14_Caspase3-7 | 68 | 72 | PF00656 | 0.557 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.413 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.400 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.269 |
DEG_APCC_DBOX_1 | 131 | 139 | PF00400 | 0.291 |
DOC_CYCLIN_yCln2_LP_2 | 31 | 37 | PF00134 | 0.487 |
DOC_MAPK_MEF2A_6 | 4 | 13 | PF00069 | 0.402 |
DOC_MIT_MIM_1 | 137 | 146 | PF04212 | 0.524 |
DOC_PP2B_LxvP_1 | 31 | 34 | PF13499 | 0.558 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.468 |
LIG_14-3-3_CanoR_1 | 132 | 142 | PF00244 | 0.465 |
LIG_14-3-3_CanoR_1 | 4 | 9 | PF00244 | 0.267 |
LIG_Actin_WH2_2 | 131 | 148 | PF00022 | 0.492 |
LIG_Actin_WH2_2 | 227 | 245 | PF00022 | 0.635 |
LIG_Actin_WH2_2 | 59 | 77 | PF00022 | 0.502 |
LIG_BIR_III_4 | 51 | 55 | PF00653 | 0.300 |
LIG_BRCT_BRCA1_1 | 138 | 142 | PF00533 | 0.510 |
LIG_BRCT_BRCA1_1 | 63 | 67 | PF00533 | 0.508 |
LIG_FHA_1 | 159 | 165 | PF00498 | 0.533 |
LIG_FHA_2 | 111 | 117 | PF00498 | 0.482 |
LIG_FHA_2 | 119 | 125 | PF00498 | 0.465 |
LIG_FHA_2 | 149 | 155 | PF00498 | 0.362 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.463 |
LIG_LIR_Gen_1 | 170 | 179 | PF02991 | 0.443 |
LIG_LIR_Gen_1 | 180 | 188 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 190 | 198 | PF02991 | 0.483 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 139 | 145 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 180 | 186 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 190 | 195 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 7 | 11 | PF02991 | 0.390 |
LIG_REV1ctd_RIR_1 | 140 | 150 | PF16727 | 0.276 |
LIG_SH2_PTP2 | 192 | 195 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 233 | 236 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.495 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.461 |
LIG_SUMO_SIM_par_1 | 147 | 154 | PF11976 | 0.396 |
LIG_SUMO_SIM_par_1 | 194 | 200 | PF11976 | 0.548 |
LIG_SUMO_SIM_par_1 | 9 | 14 | PF11976 | 0.465 |
LIG_UBA3_1 | 118 | 123 | PF00899 | 0.267 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.565 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.451 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.501 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.387 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.550 |
MOD_CK2_1 | 221 | 227 | PF00069 | 0.467 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.501 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.365 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.422 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.360 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.421 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.367 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.396 |
MOD_N-GLC_1 | 110 | 115 | PF02516 | 0.547 |
MOD_N-GLC_1 | 188 | 193 | PF02516 | 0.480 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.349 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.525 |
MOD_NEK2_1 | 188 | 193 | PF00069 | 0.272 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.447 |
MOD_NEK2_2 | 148 | 153 | PF00069 | 0.266 |
MOD_PIKK_1 | 66 | 72 | PF00454 | 0.552 |
MOD_PK_1 | 123 | 129 | PF00069 | 0.567 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.513 |
MOD_PKA_2 | 74 | 80 | PF00069 | 0.469 |
MOD_Plk_1 | 188 | 194 | PF00069 | 0.426 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.410 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.267 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.268 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.403 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.465 |
MOD_SUMO_for_1 | 206 | 209 | PF00179 | 0.285 |
MOD_SUMO_rev_2 | 124 | 131 | PF00179 | 0.566 |
TRG_DiLeu_BaEn_1 | 227 | 232 | PF01217 | 0.522 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.501 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.424 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5W4 | Leptomonas seymouri | 58% | 100% |
A0A0S4JKW0 | Bodo saltans | 27% | 70% |
A0A1X0NQF7 | Trypanosomatidae | 26% | 100% |
A0A3S7WRE7 | Leishmania donovani | 79% | 100% |
A0A422NBU0 | Trypanosoma rangeli | 30% | 100% |
A4HUN6 | Leishmania infantum | 79% | 100% |
C9ZVS5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 93% |
E9ACR0 | Leishmania major | 79% | 100% |
E9AND5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
V5BPA9 | Trypanosoma cruzi | 27% | 100% |